ARCHIVES

Politics May Play Role In FDA’s Avastin Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 21 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

DeVita Defends CHP Awards, Says Program Has High Priority

September 5, 1980

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008

Program Announcements

July 25, 1986

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987